ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
ASKA Pharmaceutical Holdings Co Ltd
Net Income
ASKA Pharmaceutical Holdings Co Ltd
Net Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
|
Net Income
ÂĄ9.9B
|
CAGR 3-Years
40%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
||
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Net Income
ÂĄ290.2B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
79%
|
CAGR 10-Years
12%
|
||
Daiichi Sankyo Co Ltd
TSE:4568
|
Net Income
ÂĄ327.7B
|
CAGR 3-Years
52%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
||
Otsuka Holdings Co Ltd
TSE:4578
|
Net Income
ÂĄ185.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-2%
|
||
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Net Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Astellas Pharma Inc
TSE:4503
|
Net Income
ÂĄ61.8B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-9%
|
ASKA Pharmaceutical Holdings Co Ltd
Glance View
ASKA Pharmaceutical Holdings Co., Ltd. engages in the management of its group companies which are involved in the manufacture and sale of pharmaceuticals, quasi-drugs, food, veterinary drugs, feeds, feed additives, and medical devices. The company is headquartered in Minato-Ku, Tokyo-To. The company went IPO on 2021-04-01. The firm mainly operates in two business segments. The Pharmaceutical segment is mainly engaged in the manufacture, purchase and sale of pharmaceutical products. The Others segment is involved in the manufacture of veterinary drugs, the provision of clinical testing services, the outsourcing of testing services, the purchase and sale of medical equipment, as well as the sale of health foods.
See Also
What is ASKA Pharmaceutical Holdings Co Ltd's Net Income?
Net Income
9.9B
JPY
Based on the financial report for Mar 31, 2024, ASKA Pharmaceutical Holdings Co Ltd's Net Income amounts to 9.9B JPY.
What is ASKA Pharmaceutical Holdings Co Ltd's Net Income growth rate?
Net Income CAGR 5Y
39%
Over the last year, the Net Income growth was 84%. The average annual Net Income growth rates for ASKA Pharmaceutical Holdings Co Ltd have been 40% over the past three years , 39% over the past five years .